Alma completes acquisition of 60% stake in PhotonMed for $40M

Alma, a Sisram Medical company, completed the acquisition of a 60% stake in PhotonMed International Ltd for 270 million RMB (approximately $40 million USD), establishing a direct operation in mainland China.

“PhotonMed's strong market presence and direct sales channels will enable us to be closer to our valued Chinese customers and reinforce our brand recognition in the region.”prnewswire.com

• 1 source
• prnewswire.comAlma, a Sisram Medical company, is establishing a direct operation in China after completing the acquisition of PhotonMedSisram Medical LtdJul 3, 2023

Summarized from public sources; check the original articles before acting on it.